Form 4: Innoviva CFO Receives Stock Options and RSUs

Innoviva, Inc. reports that Chief Financial Officer Stephen Basso was granted stock options and restricted stock units, subject to stockholder approval and vesting schedules.

Summary

• Stephen Basso, Chief Financial Officer of Innoviva, Inc., received a grant of time-vested restricted stock units (RSUs) and non-statutory stock options.
• The grant is conditional upon stockholder approval of the Issuer's 2026 Equity Incentive Plan at the annual meeting on May 4, 2026.
• 25% of the RSUs and options vest on February 20, 2027, with the remainder vesting in 12 equal quarterly installments thereafter.
• Vesting is contingent on continuous service, with accelerated vesting provisions for 'change in control' events or 'involuntary termination' within 24 months following a 'change in control' under specific conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details standard executive compensation grants contingent on stockholder approval and subject to typical vesting and acceleration clauses, without immediate financial impact or significant strategic shifts.

Positives

• Grant of equity awards (RSUs and stock options) to a key executive, signaling potential alignment of executive interests with shareholder value.
• Clear vesting schedule and conditions provide transparency regarding future equity ownership.
• Provisions for accelerated vesting in the event of a change in control or involuntary termination offer some protection to the executive.

Negatives

• The grant is conditional on stockholder approval of the 2026 Equity Incentive Plan, introducing an element of uncertainty.
• Significant portion of awards vest over an extended period, meaning the executive's full benefit is deferred.

Risks

• Risk that the 2026 Equity Incentive Plan may not be approved by stockholders, invalidating the grant.
• Potential for executive departure before vesting dates, forfeiting a portion of the awards.
• The value of the options and RSUs is subject to the future performance of Innoviva's stock price.

Future Outlook

The future outlook for the granted stock options and RSUs is dependent on the approval of the 2026 Equity Incentive Plan by stockholders and the continued service of the reporting person, Stephen Basso, through the respective vesting dates. Accelerated vesting is possible under specific change in control or termination scenarios.

Management Comments

• The Reporting Person was conditionally granted time-vested restricted stock units ("RSUs") and non-statutory stock options ("Options").
• The RSUs and Options were granted subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan at the Issuer's 2026 annual meeting of stockholders on May 4, 2026.
• Twenty-five percent of each of the RSUs and Options vest on February 20, 2027 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
• Accelerated vesting provisions are in place for 'change in control' events or 'involuntary termination' within 24 months following a 'change in control'.

Industry Context

StockSavvy.ai notes that the granting of stock options and RSUs to key executives is a common practice in the biotechnology and pharmaceutical sectors, like Innoviva, Inc., to incentivize performance and retain talent. The structure of these grants, including vesting schedules and change-in-control provisions, are standard mechanisms used to align executive interests with long-term shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: Will vote on the 2026 Equity Incentive Plan, which impacts potential dilution and executive compensation structure. The grant itself does not immediately impact share count but represents future potential dilution.
• Employees: The plan, if approved, could provide a framework for future equity awards to other employees.
• Management (Stephen Basso): Directly benefits from the potential grant of RSUs and stock options, subject to vesting and performance conditions.

Next Steps

• Stockholder vote on the Issuer's 2026 Equity Incentive Plan at the annual meeting on May 4, 2026.
• Vesting of 25% of RSUs and Options on February 20, 2027.
• Subsequent quarterly vesting of the remaining awards.

Key Dates

Keywords

Innoviva, INVA, Form 4, Stock Options, RSUs, Restricted Stock Units, Equity Incentive Plan, Executive Compensation, Beneficial Ownership, Stephen Basso, CFO